HCPLive Podcasts
Your destination feed for medical, health care and clinical science podcasts courtesy of HCPLive—featuring our shows Medical Ethics Unpacked, New Insight, and 5 Stories in Under 5.
- Update frequency
- every 7 days
- Average duration
- 19 minutes
- Episodes
- 208
- Years Active
- 2019 - 2025
ACR 22 Convergence Preview, with Dr. McMahan
Ahead of the American College of Rheumatology 2022 Convergence meeting on Nov. 10-14, our editorial team sat down with planning committee member Zsuzsanna McMahan, MD, MHS, of Johns Hopkins Universit…
00:13:04 |
Mon 07 Nov 2022
Rare Disease Report: The FDA Decision for Pompe Disease Therapy
The FDA is expected to announce the final decision for the dual therapy AT-GAA, which uses miglustat in combination with cipaglucosidase alfa for treating Pompe disease, an inherited and often times …
00:13:25 |
Fri 28 Oct 2022
Arshad Khanani, MD: A Breakthrough in Geographic Atrophy Treatment
One of the most notable topics discussed at the 2022 American Academy of Ophthalmology Meeting in Chicago was new advancements in geographic atrophy (GA) treatment.
A form of advanced age-related m…
A form of advanced age-related m…
00:12:30 |
Fri 14 Oct 2022
Rare Disease Report: Newborn Screening Awareness & Novel Diagnostic Tool
In the wake of Newborn Screening Awareness Month, this episode dives into a novel diagnostic precision medicine guidance tool called BeginNGS. Catherine Nester, RN, and Dr. Stephen Kingsmore, discuss…
00:20:46 |
Mon 10 Oct 2022
Heart Team: Making Ground on Women's Cardiovascular Health with Martha Gulati, MD
Martha Gulati, MD, Director of Preventive Cardiology, Associate Director of the Barbara Streisand Women’s Heart Center, Associate Director of Preventive and Cardiac Rehabilitation at Cedars-Sinai Med…
00:23:31 |
Wed 05 Oct 2022
Heart Team: Cardiology & Nephrology Collaborations with Dr. Matthew Weir
In the first episode from this new cardiovascular medicine series, hosts Dr. Jorge Plutzky and Dr. Michael Farkouh speak with University of Maryland's Dr. Matthew Weir about the growing involvement o…
00:31:14 |
Tue 06 Sep 2022
Rare Disease Report: CDKL5 Deficiency Disorder Expert Interview
The second episode of the 2-part Rare Disease Report shifts to a clinical perspective with the expertise of Dr. Pestana, a pediatric epileptologist at the Epilepsy Center, Cleveland Clinic Neurologic…
00:19:05 |
Fri 02 Sep 2022
Rare Disease Report: CDKL5 Deficiency Disorder
In the first episode of a 2-part Rare Disease Report, Whitney Mitchell, mother and caregiver to her 6 year old daughter Havilah, shared her experience leading up to, and now living with, Havilah’s CD…
00:23:51 |
Wed 31 Aug 2022
The Biggest Discussions in Retina from the 2022 ASRS Annual Meeting
This past week, the American Society of Retina Specialists (ASRS) held its 40th Annual Meeting in New York City to discuss landmark data and the newest advancements in retina care.
The HCPLive tea…
00:13:46 |
Wed 20 Jul 2022
FDA Approves Ruxolitinib: New Horizons in Vitiligo Care
On Monday, the US Food and Drug Administration (FDA) approved ruxolitinib cream 1.5% for the treatment of nonsegmental vitiligo in adults and pediatric patients 12 years and older, making it both th…
00:08:13 |
Wed 20 Jul 2022
How Pegloticase Plus Methotrexate is Breaking Ground in Gout Care
Last week, the US Food and Drug Administration (FDA) approved the co-treatment of pegloticase (Krystexxa) injection plus methotrexate (MTX) for uncontrolled gout, a decision bolstered by data from ph…
00:15:57 |
Tue 12 Jul 2022
What Ustekinumab Provides in Long-Term IBD Care
Despite a bevy of biologics available for people struggling with Crohn’s disease and ulcerative colitis (UC), not all patients are able to respond to or tolerate a vast majority of approved therapies…
00:14:15 |
Wed 29 Jun 2022
Exploring New Horizons in Ophthalmology Care with Gene Therapy
If you’ve been keeping an eye on recent developments in ophthalmic care, then you’ll know that several new therapeutic agents that had been approved by the US Food and Drug Administration (FDA) in re…
00:09:13 |
Mon 27 Jun 2022
How the Newest Dupilumab Approval Solves an "Unmet Need" in Children with AD
Earlier this month, dupilumab became the first and only biologic medicine approved by the US Food and Drug Administration for the treatment of atopic dermatitis in patients of all ages, from infancy …
00:17:14 |
Mon 20 Jun 2022
Dermatologists Discuss the FDA Approval of Baricitinib for Alopecia Areata
On June 13, the US Food and Drug Administration (FDA) approved oral baricitinib (Olumiant) tablets for the treatment of severe alopecia areata in adults, which marked the first approval of a systemic…
00:22:38 |
Thu 16 Jun 2022
Dermatologists Discuss the FDA Approval of Baricitinib for Alopecia Areata
On June 13, the US Food and Drug Administration (FDA) approved oral baricitinib (Olumiant) tablets for the treatment of severe alopecia areata in adults, which marked the first approval of a systemi…
00:22:09 |
Thu 16 Jun 2022
Disclaimer: The podcast and artwork embedded on this page are the property of HCPLive.com. This content is not affiliated with or endorsed by eachpod.com.